She has received a one-year Pilot Award to test the possible uterine origin of LAM. Dr. Kim will be examining whether additional LAM lesions express the same molecules as uterine tissues and also work to model the disease in mice by inducing a LAM-specific mutation directly within the uterus. Dr. Kim believes that the proposed studies will not only clarify the origins of LAM, but will aid in the development of novel therapeutic avenues.